Fasenra pen 30MG/ML 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTLS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,494
Award facts
- Contract value 100% obligated
- $2,493.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,493.75 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Fasenra Pen 30mg/ml. The award, issued on January 14, 2026, with an ultimate completion date of February 11, 2026, utilizes firm fixed-price pricing with no set-aside designation. DMS Pharmaceutical Group will perform the delivery from its Park Ridge facility, leveraging its established position as a critical pharmaceutical supplier within the Department of Defense healthcare supply chain.
This delivery order falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for military healthcare facilities worldwide. The parent contract, valued at $499,999,999 with a completion date of December 31, 2036, positions the company as one of multiple regional prime vendor contractors authorized to supply a comprehensive range of pharmaceuticals including branded and generic prescription drugs, biologics, and medical consumables to support the Department of Defense's global medical operations.
Quick answers
Who was awarded contract SPE2DR26FBTLS?
SPE2DR26FBTLS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FBTLS worth?
The government has obligated $2,494 on SPE2DR26FBTLS.
Is contract SPE2DR26FBTLS an order under another contract?
Yes. SPE2DR26FBTLS is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTLS competed?
The extent of competition for SPE2DR26FBTLS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award